The equity investment from iNovia and VIMAC
will fund development activities for MIM-D3 up to and including the completion of both Phase I safety and tolerability and Phase II proof of concept studies in humans.
Milestone Medica Fund (VMM) is a life sciences venture capital fund providing equity financing to entrepreneurial companies.
We look forward to working with VIMAC
Ventures and Commons Capital to build a company that we believe will have a significant impact on women's health.
Ventures LLC is a Boston-based venture capital firm that invests primarily in emerging growth companies located in the northeastern United States and Canada.
Tessella, Triple Play Integration (TPI), VayUSA and VIMAC
the leader in distributed data management, today announced that it has raised $10 million in a round led by new investor North Bridge Venture Partners, along with participation from existing investors Boston Capital Ventures and VIMAC
The financing was led by BDC Venture Capital and Boston-based VIMAC
Milestone Medica Fund (VMM).
The round was led by VIMAC
Ventures of Boston and included the participation of EDC Equity, the equity finance arm of Export Development Canada (EDC), as well as existing investors VenGrowth Capital Partners and MMV Financial Inc.
One EDF Ventures The Angels' Forum/The Halo Funds Emergence Capital Partners VIMAC
Milestone Medica, Quaker BioVentures, and The Aurora Funds Co-lead Investment in Pennsylvania-based Company
Mark Robinson is a director with VIMAC
, where he leads investment activities in the Internet and IT/communications sectors.
Present shareholders VIMAC
Ventures, LLC (Boston, MA) and American Bailey Ventures LLC (Stamford, CT) also participated in the Series C financing.